BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

BIT:1BAYN • DE000BAY0017

45.95 EUR
-0.05 (-0.11%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

1BAYN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. 1BAYN may be in some trouble as it scores bad on both profitability and health. 1BAYN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • 1BAYN had positive earnings in the past year.
  • 1BAYN had a positive operating cash flow in the past year.
  • In multiple years 1BAYN reported negative net income over the last 5 years.
  • Each year in the past 5 years 1BAYN had a positive operating cash flow.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

  • 1BAYN's Return On Assets of -0.19% is on the low side compared to the rest of the industry. 1BAYN is outperformed by 70.91% of its industry peers.
  • With a Return On Equity value of -0.67%, 1BAYN is not doing good in the industry: 70.91% of the companies in the same industry are doing better.
  • 1BAYN's Return On Invested Capital of 1.92% is on the low side compared to the rest of the industry. 1BAYN is outperformed by 67.27% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1BAYN is significantly below the industry average of 14.21%.
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROIC 1.92%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.87%
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • Looking at the Operating Margin, with a value of 4.20%, 1BAYN is doing worse than 69.09% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1BAYN has declined.
  • Looking at the Gross Margin, with a value of 56.35%, 1BAYN is doing worse than 72.73% of the companies in the same industry.
  • 1BAYN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.2%
PM (TTM) N/A
GM 56.35%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • 1BAYN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, 1BAYN has about the same amount of shares outstanding.
  • Compared to 5 years ago, 1BAYN has about the same amount of shares outstanding.
  • Compared to 1 year ago, 1BAYN has an improved debt to assets ratio.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • Based on the Altman-Z score of 1.03, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.03, 1BAYN is not doing good in the industry: 76.36% of the companies in the same industry are doing better.
  • 1BAYN has a debt to FCF ratio of 10.07. This is a negative value and a sign of low solvency as 1BAYN would need 10.07 years to pay back of all of its debts.
  • 1BAYN has a worse Debt to FCF ratio (10.07) than 61.82% of its industry peers.
  • 1BAYN has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • 1BAYN's Debt to Equity ratio of 1.11 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 67.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Altman-Z 1.03
ROIC/WACC0.27
WACC7.17%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that 1BAYN should not have too much problems paying its short term obligations.
  • The Current ratio of 1BAYN (1.14) is worse than 63.64% of its industry peers.
  • A Quick Ratio of 0.71 indicates that 1BAYN may have some problems paying its short term obligations.
  • 1BAYN has a Quick ratio of 0.71. This is in the lower half of the industry: 1BAYN underperforms 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.71
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • 1BAYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.72%.
  • The Earnings Per Share has been decreasing by -5.27% on average over the past years.
  • The Revenue has decreased by -1.87% in the past year.
  • Measured over the past years, 1BAYN shows a small growth in Revenue. The Revenue has been growing by 1.37% on average per year.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.51% on average over the next years.
  • 1BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.22% yearly.
EPS Next Y-5.02%
EPS Next 2Y-1.64%
EPS Next 3Y1.75%
EPS Next 5Y3.51%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • 1BAYN is valuated reasonably with a Price/Earnings ratio of 8.60.
  • Based on the Price/Earnings ratio, 1BAYN is valued cheaply inside the industry as 92.73% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.97, 1BAYN is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.41, which indicates a very decent valuation of 1BAYN.
  • Based on the Price/Forward Earnings ratio, 1BAYN is valued cheaply inside the industry as 89.09% of the companies are valued more expensively.
  • 1BAYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.96.
Industry RankSector Rank
PE 8.6
Fwd PE 9.41
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 1BAYN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1BAYN is cheaper than 63.64% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, 1BAYN is valued cheaply inside the industry as 89.09% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.47
EV/EBITDA 12.41
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.64%
EPS Next 3Y1.75%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.25%, 1BAYN is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.94, 1BAYN is paying slightly less dividend.
  • With a Dividend Yield of 0.25, 1BAYN pays less dividend than the S&P500 average, which is at 1.79.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

  • The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • The earnings of 1BAYN are negative and hence is the payout ratio. 1BAYN will probably not be able to sustain this dividend level.
DP-65.15%
EPS Next 2Y-1.64%
EPS Next 3Y1.75%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

Find the best dividend stocksShow peers with best dividend

BAYER AG-REG

BIT:1BAYN (2/13/2026, 7:00:00 PM)

45.95

-0.05 (-0.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12
Earnings (Next)02-25
Inst Owners49.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap45.14B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts74.29
Price Target42.2 (-8.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)25.79%
PT rev (3m)45.17%
EPS NQ rev (1m)11.15%
EPS NQ rev (3m)-30.17%
EPS NY rev (1m)0.15%
EPS NY rev (3m)1.01%
Revenue NQ rev (1m)0.54%
Revenue NQ rev (3m)-1.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 8.6
Fwd PE 9.41
P/S 0.98
P/FCF 11.47
P/OCF 6.71
P/B 1.53
P/tB N/A
EV/EBITDA 12.41
EPS(TTM)5.34
EY11.62%
EPS(NY)4.89
Fwd EY10.63%
FCF(TTM)4.01
FCFY8.72%
OCF(TTM)6.84
OCFY14.89%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROCE 2.56%
ROIC 1.92%
ROICexc 2.13%
ROICexgc 7.24%
OM 4.2%
PM (TTM) N/A
GM 56.35%
FCFM 8.58%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.87%
ROIC(5y)N/A
ROICexc(3y)6.62%
ROICexc(5y)N/A
ROICexgc(3y)27.47%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Debt/EBITDA 5.32
Cap/Depr 66.1%
Cap/Sales 6.08%
Interest Coverage 1.09
Cash Conversion 109.39%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.71
Altman-Z 1.03
F-Score5
WACC7.17%
ROIC/WACC0.27
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-5.02%
EPS Next 2Y-1.64%
EPS Next 3Y1.75%
EPS Next 5Y3.51%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year65.28%
EBIT Next 3Y21.41%
EBIT Next 5Y12.99%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%

BAYER AG-REG / 1BAYN.MI FAQ

What is the fundamental rating for 1BAYN stock?

ChartMill assigns a fundamental rating of 2 / 10 to 1BAYN.MI.


What is the valuation status of BAYER AG-REG (1BAYN.MI) stock?

ChartMill assigns a valuation rating of 6 / 10 to BAYER AG-REG (1BAYN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for BAYER AG-REG?

BAYER AG-REG (1BAYN.MI) has a profitability rating of 2 / 10.


What are the PE and PB ratios of BAYER AG-REG (1BAYN.MI) stock?

The Price/Earnings (PE) ratio for BAYER AG-REG (1BAYN.MI) is 8.6 and the Price/Book (PB) ratio is 1.53.


Can you provide the expected EPS growth for 1BAYN stock?

The Earnings per Share (EPS) of BAYER AG-REG (1BAYN.MI) is expected to decline by -5.02% in the next year.